BIOCOMPATIBILITY AND RISK OF INFECTION IN HEMODIALYSIS-PATIENTS

被引:0
作者
HIMMELFARB, J
HAKIM, RM
机构
[1] MAINE MED CTR,PORTLAND,ME 04102
[2] VANDERBILT UNIV,MED CTR,NASHVILLE,TN 37240
关键词
BIOCOMPATIBILITY; COMPLEMENT ACTIVATION; GRANULOCYTES; INFECTION; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES;
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Infection remains a major cause of morbidity and mortality in the dialysis patient. Most of these infections are bacterial and often lead to sepsis. In this review the possible influence of the biocompatibility of the dialysis membrane on the incidence of bacterial infections is discussed. Specifically, the role of the membrane on granulocyte function such as phagocytosis, adhesion, and production of reactive oxygen species is shown to be adversely affected by recurrent exposure to complement-activating membranes. Recent clinical studies also support the notion that dialysis with bioincompatible membranes is associated with a higher incidence of clinical infections than membranes that are more biocompatible.
引用
收藏
页码:138 / 144
页数:7
相关论文
共 46 条
[1]   GRANULOCYTE FUNCTION IN PATIENTS WITH CHRONIC RENAL-FAILURE - SURFACE ADHERENCE, PHAGOCYTOSIS, AND BACTERICIDAL ACTIVITY INVITRO [J].
ABRUTYN, E ;
SOLOMONS, NW ;
STCLAIR, L ;
MACGREGOR, RR ;
ROOT, RK .
JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (01) :1-8
[2]   INCREASED EXPRESSION OF AN ADHESION-PROMOTING SURFACE GLYCOPROTEIN IN THE GRANULOCYTOPENIA OF HEMODIALYSIS [J].
ARNAOUT, MA ;
HAKIM, RM ;
TODD, RF ;
DANA, N ;
COLTEN, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (08) :457-462
[3]   INVIVO T-CELL PREACTIVATION IN CHRONIC UREMIC HEMODIALYZED AND NON-HEMODIALYZED PATIENTS [J].
BEAURAIN, G ;
NARET, C ;
MARCON, L ;
GRATEAU, G ;
DRUEKE, T ;
URENA, P ;
NELSON, DL ;
BACH, JF ;
CHATENOUD, L .
KIDNEY INTERNATIONAL, 1989, 36 (04) :636-644
[4]   CUPRAMMONIUM MEMBRANES STIMULATE INTERLEUKIN-1 RELEASE AND ARACHIDONIC-ACID METABOLISM IN MONOCYTES IN THE ABSENCE OF COMPLEMENT [J].
BETZ, M ;
HAENSCH, GM ;
RAUTERBERG, EW ;
BOMMER, J ;
RITZ, E .
KIDNEY INTERNATIONAL, 1988, 34 (01) :67-73
[5]  
BJORKSTEN B, 1978, ACTA MED SCAND, V203, P67
[6]  
BRIGGS WA, 1983, KIDNEY INT S16, V24, pS93
[7]  
COHEN MS, 1982, BLOOD, V60, P1283
[8]   THE LONG-TERM CLINICAL COURSE OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN END-STAGE RENAL-DISEASE [J].
COPLON, NS ;
DISKIN, CJ ;
PETERSEN, J ;
SWENSON, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (04) :186-190
[9]  
CROSNIER J, 1981, LANCET, V1, P797
[10]   CYTOKINES - AGENTS-PROVOCATEURS IN HEMODIALYSIS [J].
DINARELLO, CA ;
HARRINGTON, JT ;
KING, A ;
KASSIRER, JP ;
LEVEY, AS ;
MEYER, K ;
KURTIN, P ;
GELFAND, J ;
PEREIRA, BJG ;
SINGH, A .
KIDNEY INTERNATIONAL, 1992, 41 (03) :683-694